Bioremediation of Triphenyl phosphate (cas 115-86-6) by Brevibacillus brevis: Degradation characteristics and role of cytochrome P450 monooxygenase

Add time:08/31/2019    Source:sciencedirect.com

Triphenyl phosphate (cas 115-86-6) (TPHP) has been detected with increasing frequency in environmental samples, which has aroused great attention regarding its potential adverse effects. In this study, biodegradation of TPHP by Brevibacillus brevis was investigated. The results revealed that the highest degradation efficiency of 3 μmol/L TPHP by B. brevis reached 92.1% at pH 7 and 30 °C. The major metabolites of TPHP, diphenyl phosphate and phenyl phosphate were detected within 5 days of incubation with the maximum concentrations at 308.2 and 11.8 nmol/L, respectively. The activities of superoxide dismutase and catalase along with malondialdehyde content also increased significantly, indicating that TPHP caused a severe oxidative stress on B. brevis. Meanwhile, the addition of cytochrome P450 (CYP) inhibitor piperonyl butoxide markedly decreased the degradation of TPHP by B. brevis. Further transcription studies using quantitative real-time RT-PCR confirmed that the expression of CYP gene in B. brevis were significantly down-regulated. These findings demonstrated the important role of CYP in the degradation of TPHP. To our best knowledge, this is the first report about the biodegradation of TPHP by B. brevis. Overall, this study provides new insights into the potential mechanisms of TPHP biodegradation by microorganisms.

We also recommend Trading Suppliers and Manufacturers of Triphenyl phosphate (cas 115-86-6). Pls Click Website Link as below: cas 115-86-6 suppliers

Prev:Neonatal Triphenyl phosphate (cas 115-86-6) and its metabolite diphenyl phosphate exposure induce sex- and dose-dependent metabolic disruptions in adult mice☆
Next:Research paperStructure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120)